Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Development of a novel Live Attenuated Influenza A Virus vaccine encoding the IgA-inducing protein

Version 1 : Received: 4 June 2021 / Approved: 7 June 2021 / Online: 7 June 2021 (13:03:43 CEST)

How to cite: Cáceres, C.J.; Cardenas-Garcia, S.; Jain, A.; Gay, L.C.; Carnaccini, S.; Seibert, B.; Ferreri, L.M.; Geiger, G.; Jasinskas, A.; Nakajima, R.; Rajao, D.S.; Isakova-Sivak, I.; Rudenko, L.; Vincent, A.L.; Davies, D.H.; Perez, D.R. Development of a novel Live Attenuated Influenza A Virus vaccine encoding the IgA-inducing protein. Preprints 2021, 2021060180 (doi: 10.20944/preprints202106.0180.v1). Cáceres, C.J.; Cardenas-Garcia, S.; Jain, A.; Gay, L.C.; Carnaccini, S.; Seibert, B.; Ferreri, L.M.; Geiger, G.; Jasinskas, A.; Nakajima, R.; Rajao, D.S.; Isakova-Sivak, I.; Rudenko, L.; Vincent, A.L.; Davies, D.H.; Perez, D.R. Development of a novel Live Attenuated Influenza A Virus vaccine encoding the IgA-inducing protein. Preprints 2021, 2021060180 (doi: 10.20944/preprints202106.0180.v1).

Abstract

Live attenuated influenza virus (LAIV) vaccines elicit a combination of systemic and mucosal immunity by mimicking a natural infection. To further enhance protective mucosal responses, we incorporated the gene encoding the IgA-inducing protein (IGIP) into the LAIV genomes of the cold-adapted A/Leningrad/134/17/57 (H2N2) strain (caLen) and the experimental attenuated backbone A/turkey/Ohio/313053/04 (H3N2) (OH/04att). Incorporation of IGIP into the caLen background led to a virus that grew poorly in prototypical substrates. In contrast, IGIP in the OH/04att background (IGIP-H1att) virus grew to titers comparable to the isogenic backbone H1att (H1N1) without IGIP. IGIP-H1att- and H1caLen-vaccinated mice were protected against lethal challenge with a homologous virus. The IGIP-H1att vaccine generated robust serum HAI responses in naïve mice against the homologous virus, equal or better than those obtained with the H1caLen vaccine. Analyses of IgG and IgA responses using a protein microarray revealed qualitative differences in humoral and mucosal responses between vaccine groups. Overall, serum and bronchoalveolar lavage samples from the IGIP-H1att group showed trends towards increased stimulation of IgG and IgA responses compared to H1caLen samples. In summary, introduction of genes encoding immunomodulatory functions into a candidate LAIV that can serve as natural adjuvants to improve overall vaccine safety and efficacy.

Subject Areas

LAIV, Influenza, HA, IGIP, IgA, IgG, vaccine, natural adjuvant

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.